Jiang-Ning Zhou Selected Research

Jiang-Ning Zhou Research Topics

Disease

17	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 09/2002
10	Mood Disorders (Mood Disorder) 11/2020 - 06/2005
5	Amyloid Plaque 11/2016 - 05/2003
4	Major Depressive Disorder (Major Depressive Disorders) 01/2018 - 02/2007
3	Hypothyroidism 04/2014 - 11/2006
3	Glioma (Gliomas) 01/2013 - 10/2007
3	Cognitive Dysfunction 04/2007 - 09/2002
2	Depressive Disorder (Melancholia) 01/2020 - 10/2010
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2018 - 06/2013
2	Stroke (Strokes) 08/2009 - 02/2007
2	Neuroblastoma 08/2008 - 04/2008
2	Brain Ischemia (Cerebral Ischemia) 09/2007 - 02/2007
2	Ischemia 09/2007 - 02/2007
1	Inflammation (Inflammations) 01/2021
1	Gliosis 01/2016
1	Dementia (Dementias) 01/2016
1	Hyperglycemia 02/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2014
1	Obesity 02/2013
1	Insulin Resistance 02/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2012
1	Breast Neoplasms (Breast Cancer) 08/2011
1	Body Weight (Weight, Body) 08/2010
1	Hypoxia (Hypoxemia) 05/2010
1	Atrophy 08/2009
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2009
1	Seizures (Absence Seizure) 11/2008
1	Memory Disorders (Memory Loss) 09/2007
1	Reperfusion Injury 02/2007
1	Sleep Deprivation 08/2002

Drug/Important Bio-Agent (IBA)

8	MelatoninIBA 01/2013 - 09/2003
5	Corticotropin-Releasing HormoneIBA 11/2020 - 06/2005
4	Messenger RNA (mRNA)IBA 01/2018 - 08/2008
4	Apolipoproteins E (ApoE)IBA 11/2014 - 09/2002
4	ApolipoproteinsIBA 11/2014 - 09/2002
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020 - 04/2008
3	Estrogens (Estrogen)FDA Link 02/2013 - 09/2003
3	Fluoxetine (Prozac)FDA LinkGeneric 11/2008 - 02/2007
2	RetinoidsIBA 01/2020 - 01/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 12/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018 - 01/2015
2	indacrinoneIBA 11/2016 - 07/2012
2	Bromodeoxyuridine (BrdU)IBA 01/2016 - 09/2007
2	Glucose (Dextrose)FDA LinkGeneric 02/2015 - 02/2013
2	NeuropeptidesIBA 06/2013 - 01/2009
2	Amyloid beta-PeptidesIBA 12/2012 - 05/2003
2	LithiumIBA 09/2007 - 02/2007
2	Neuroprotective AgentsIBA 09/2007 - 02/2007
2	Thyroid HormonesIBA 06/2007 - 11/2006
2	Estrogen Receptor alphaIBA 03/2004 - 10/2003
1	Toll-Like Receptor 4IBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	SteroidsIBA 01/2018
1	Dehydroepiandrosterone (DHEA)IBA 01/2018
1	EnzymesIBA 01/2018
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2015
1	LipidsIBA 04/2014
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 06/2013
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2013
1	Vasopressins (Vasopressin)IBA 06/2013
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 06/2013
1	Melatonin Receptors (Melatonin Receptor)IBA 06/2013
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2013
1	Peptides (Polypeptides)IBA 12/2012
1	Proteins (Proteins, Gene)FDA Link 12/2012
1	ResveratrolIBA 12/2012
1	Coloring Agents (Dyes)IBA 12/2012
1	Letrozole (Femara)FDA LinkGeneric 08/2011
1	Pharmaceutical PreparationsIBA 08/2011
1	Aromatase InhibitorsIBA 08/2011
1	Sucrose (Saccharose)IBA 08/2010
1	tau Proteins (tau Protein)IBA 05/2010
1	Retinoic Acid Receptor alphaIBA 11/2009
1	Apolipoprotein E3IBA 08/2009
1	Apolipoprotein E4IBA 08/2009
1	Serotonin ReceptorsIBA 01/2009
1	gamma-Aminobutyric Acid (GABA)IBA 09/2008
1	Therapeutic UsesIBA 08/2007
1	Serotonin (5 Hydroxytryptamine)IBA 08/2007
1	MT1 Melatonin ReceptorIBA 08/2007
1	Drinking WaterIBA 06/2007
1	Synaptotagmin IIBA 04/2007
1	Nogo ReceptorsIBA 03/2007
1	Hormones (Hormone)IBA 11/2006
1	ORALIT (ORS)IBA 06/2005
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2005
1	Synapsins (Synapsin I)IBA 03/2004
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2002
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 08/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2016
1	Therapeutics 06/2013
1	Ovariectomy (Oophorectomy) 02/2013
1	Denervation 02/2013
1	Aftercare (After-Treatment) 08/2007